These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28414496)

  • 1. Impaired psychomotor function and plasma methadone and levo-alpha-acetylmethadol (LAAM) concentrations in opioid-substitution patients.
    Newcombe DAL; Somogyi AA; Bochner F; White JM
    Exp Clin Psychopharmacol; 2017 Jun; 25(3):223-233. PubMed ID: 28414496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
    Newcombe DA; Bochner F; White JM; Somogyi AA
    Drug Alcohol Depend; 2004 Oct; 76(1):63-72. PubMed ID: 15380290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
    Borg L; Ho A; Wells A; Joseph H; Appel P; Moody D; Kreek MJ
    J Addict Dis; 2002; 21(3):13-22. PubMed ID: 12094997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine.
    McCance-Katz EF; Rainey PM; Smith P; Morse GD; Friedland G; Boyarsky B; Gourevitch M; Jatlow P
    Am J Addict; 2006; 15(1):23-34. PubMed ID: 16449090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
    Longshore D; Annon J; Anglin MD; Rawson RA
    Addiction; 2005 Aug; 100(8):1131-9. PubMed ID: 16042643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of levo-alpha-acetylmethadol and its metabolites on schedule-controlled behavior in the pigeon.
    McGivney WT; McMillan DE
    J Pharmacol Exp Ther; 1981 Feb; 216(2):299-305. PubMed ID: 7463351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).
    Tennant FS; Rawson RA; Pumphrey E; Seecof R
    J Subst Abuse Treat; 1986; 3(3):195-202. PubMed ID: 3806733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma l-alpha-Acetylmethadol (LAAM) after acute and chronic administration.
    Henderson GL; Wilson BK; Lau DH
    Clin Pharmacol Ther; 1977 Jan; 21(1):16-25. PubMed ID: 832446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. l-alpha-Acetylmethadol, l-alpha-acetyl-N-normethadol and l-alpha-acetyl-N,N-dinormethadol: comparisons with morphine and methadone in suppression of the opioid withdrawal syndrome in the dog.
    Vaupel DB; Jasinski DR
    J Pharmacol Exp Ther; 1997 Nov; 283(2):833-42. PubMed ID: 9353405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of opioid substitution therapy on alcohol metabolism.
    Clark NC; Dietze P; Lenné MG; Redman JR
    J Subst Abuse Treat; 2006 Apr; 30(3):191-6. PubMed ID: 16616162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials.
    Glanz M; Klawansky S; McAullife W; Chalmers T
    Am J Addict; 1997; 6(4):339-49. PubMed ID: 9398932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status.
    Anglin MD; Conner BT; Annon J; Longshore D
    Addiction; 2007 Sep; 102(9):1432-42. PubMed ID: 17697277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of LAAM and methadone utilization in an opiate agonist treatment program.
    Valdivia JF; Khattak S
    Mt Sinai J Med; 2000; 67(5-6):398-403. PubMed ID: 11064490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine.
    Ling W; Rawson RA; Compton MA
    J Psychoactive Drugs; 1994; 26(2):119-28. PubMed ID: 7931856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical role of cytochrome P450 3A in the bioactivation and clinical effects of levo-alpha-acetylmethadol: importance of clinical investigations to validate in vitro drug metabolism studies.
    Kharasch ED; Whittington D; Hoffer C; Krudys K; Craig K; Vicini P; Sheffels P; Lalovic B
    Clin Pharmacokinet; 2005; 44(7):731-51. PubMed ID: 15966756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levo-Alpha Acetyl Methadol (LAAM). Its advantages and drawbacks.
    Finn P; Wilcock K
    J Subst Abuse Treat; 1997; 14(6):559-64. PubMed ID: 9437627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ].
    Petersen H; Skauge L; Svejsø J; Ege PP
    Ugeskr Laeger; 2000 Nov; 162(48):6553-6. PubMed ID: 11187226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial.
    Wieneke H; Conrads H; Wolstein J; Breuckmann F; Gastpar M; Erbel R; Scherbaum N
    Eur J Med Res; 2009 Jan; 14(1):7-12. PubMed ID: 19258204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.